MANNATECH INC Foreign Currency Transaction Gain Loss After Tax
MANNATECH INC (MTEX) reported Foreign Currency Transaction Gain Loss After Tax of $2.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossAfterTax · last filed 2026-04-15
- MANNATECH INC foreign currency transaction gain loss after tax for fiscal 2025 was $2.10M, a 19.23% decline from fiscal 2024.
- MANNATECH INC foreign currency transaction gain loss after tax for fiscal 2024 was $2.60M.
| Period end | Foreign Currency Transaction Gain Loss After Tax 12 month |
|---|---|
| 2025-12-31 | $2.10M 10-K · filed 2026-04-15 |
| 2024-12-31 | $2.60M 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |